(Q71394472)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

medroxyprogesterone acetate

1 reference

M Salimtschik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

H T Mouridsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

J Loeber

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

E Johansson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 January 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

267-269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00255272

18 October 2019

exact match

0 references

cites work

High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy

1 reference

12 December 2020

Progestin therapy of breast cancer: comparison of agents

1 reference

12 December 2020

Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1

1 reference

12 December 2020

High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response Evaluation

1 reference

12 December 2020

Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma.

1 reference

12 December 2020

Hormonal therapy in cancer of the breast. XXIV. Effect of corticosterone or medroxyprogesterone acetate on clinical course and hormonal excretion

1 reference

12 December 2020

High Dose Medroxyprogesterone-Acetate Treatment in Advanced Mammary Carcinoma: A Phase II Investigation

1 reference

12 December 2020

Treatment of breast cancer with medroxyprogesterone acetate

1 reference

12 December 2020

A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate

1 reference

12 December 2020

Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women

1 reference

12 December 2020

Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally

1 reference

12 December 2020

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00255272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7438329%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference